Details of the Drug

General Information of Drug (ID: DMKM3II)

Drug Name

ALS-4

Indication

Disease Entry	ICD 11	Status	REF
Staphylococcus infection	1B5Y	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecule

Cross-matching ID

References

1	ClinicalTrials.gov (NCT05274802) A Phase I, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of ALS-4 (IM032) Administered Orally to Healthy Volunteers. U.S.National Institutes of Health.